Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma

NCT04233697 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Investigator left institution

Conditions

Lymphoma, T-Cell

Interventions

DRUG: Copanlisib
DRUG: Romidepsin

Sponsor

Columbia University

Collaborators

[object Object]